Leading the commercialization efforts at Perthera. Powering Healthcare providers to deliver Best in Class Precision Cancer Care to improve patient outcomes and save lives.

As an award winning, Boston-based architecture and design firm, Arrowstreet harnesses its depth of knowledge and creative thinking to solve the diverse building challenges across a wide range of sectors and building types. I added my financial and business acumen to this creative thinking to tighten up the financial ship.

Neuronix has developed NeuroAD, a non-pharmaceutical, non-invasive treatment for Alzheimer’s disease (AD). The patented NeuroAD System combines transcranial magnetic stimulation and cognitive training to increase the cognitive capabilities of patients with mild to moderate AD. The NeuroAD System has seen significant outcomes across multiple worldwide clinical trials, yielding stronger results than those obtained utilizing pharmaceutical options alone, with minimal side effects for patients. The CE-approved NeuroAD System is now available at private clinics and NeuroAD treatment centers across Europe.

Sales & Marketing support. Worked with Sales to provide sales quotes and process orders for globally based customers. Worked with Marketing to publicize webinars and other educational events sponsored by BioScale, to provide Trade Show logistical support and to manage and update website and other digital marketing platforms. Worked with Finance to move orders from production to shipping.

I coordinated all activities of the Brian Herr for US Senate team to "Retire Ed Markey"!I coordinated volunteers, provided outreach to voters, organized and staffed fundraisers and other events, and coordinated press relations and communications.We achieved more than 30% of the votes, with a grassroots campaign against a lifetime politician with deep pockets.

• Renewable Energy Development Capital Company, currently securing additional development capital investments up to $15 million while simultaneously conducting due diligence on energy project portfolio candidates.• Coordinated origination, screening, financial modeling and analysis of potential renewable energy investment opportunities: combined heat and power (CHP), biomass, solar, wind, distributed generation and other renewable and sustainable technologies. • Average project size: $75 million.• Lead investment due diligence; research of industry, competitor, and business activities; strategy development; and deal sourcing and structuring.• Negotiated non-disclosure, development funding and project participation agreements, including Purchase and Sale Agreements, Mutual Release agreements, Engagement Letters and Letters of Intent to Purchase.• Drafted and distributed investment and marketing materials including Private Placement Memorandum, Investment Summary and Market Analysis presentations, to potential investors and development partners.

• Ken Burns documentary film: "Defying the Nazis: The Sharps' War" is now on PBS (premiered on September 20, 2016).• Prepared and distributed marketing, distribution and promotion materials for over 200 screenings across the country.• Oversaw financial reporting for $65,000 annual budget; coordinated post-production work-flow and developed strategies for process improvement and implementation.

• Prepared financial reports, budgets, forecasts and analyses for recovery and cost containment company operating in the insurance industry.• Provided process improvement initiatives for second injury fund recovery company . • Completed ad hoc research projects to support insurance specialists.

Advised European and US clients on international investment banking transactions, including mergers, acquisitions, leveraged buyouts, purchase and sale agreements, public stock offerings, and interest rate and currency swaps. Skills include:• Prepared and delivered presentations to CEO level clients.• Determined strategies for and negotiated cross-border transactions.• Created computer models to determine company valuations.• Prepared product, company and industry profiles.• Analyzed feasibility of and determined alternative structures for leveraged buyouts.• Prepared selling memorandum for exclusive sell arrangements.• Documented and closed a variety of investment banking transactions.Notable transactions include:• Advised Swiss client in its recommended public takeover offer for a UK personnel services company.• Represented US principal in the sale of its optical products company to a UK corporation.• Advised Irish client in the sale of its 30% strategic stake in an Irish company to a French corporation.Unique Contributions:• Promoted to Vice President in half the usual time. Completed 2-year Corporate Finance Training Program in twelve months.• Chosen by senior management to further develop training courses and classroom segments of the Associate Training Program.

Developed divisional operating budget for presentation to senior management. Prepared profitability and quantity and discount analysis studies on division's five operating regions. Provided financial models and analysis to assist marketing staff in determining optimal promotion strategies for leading brands.

Conducted pre-clinical toxicity studies of cancer therapeutic agents using monoclonal antibody technology. Coordinated laboratory purchasing, radiation safety and other functions within this newly formed biotechnology company.

Assisted in the development of research strategies for macro-molecular carriers of cancer agents. Coordinated the research activities of two technicians and three graduate students.